Well if this is new management & ANOTHER new project lets see.From the most disappointing hopeless stock on the ASX this will take alot to turn around.Cheers M.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%